Effect of pregnancy on emtricitabine pharmacokinetics-Reference-Cited by-同舟云学术

Effect of pregnancy on emtricitabine pharmacokinetics

Published:2011-11-30 Issue: Volume: Page:n/a-n/a
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Stek AM¹,Best BM,Luo W²,Capparelli E,Burchett S³,Hu C⁴,Li H⁴,Read JS⁵,Jennings A⁶,Barr E⁷,Smith E⁸,Rossi SS⁹,Mirochnick M¹⁰

Affiliation:

1. Department of Obstetrics and Gynecology; University of Southern California School of Medicine; Los Angeles; CA; USA

2. Skaggs School of Pharmacy and Pharmaceutical Sciences; University of California San Diego; La Jolla; CA; USA

3. Children's Hospital; Boston; MA; USA

4. Statistical and Data Analysis Center; Harvard School of Public Health; Boston; MA; USA

5. Pediatric, Adolescent, and Maternal AIDS Branch; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Bethesda; MD; USA

6. Frontier Science and Technology Research Foundation; Amherst; NY; USA

7. The Children's Hospital; Aurora; CO; USA

8. National Institute of Allergy and Infectious Diseases; Bethesda; MD; USA

9. Department of Pediatrics; University of California San Diego, Rady Children's Hospital San Diego; San Diego; CA; USA

10. Boston University School of Medicine; Boston; MA; USA

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2011.00965.x/fullpdf

Reference26 articles.

1. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States 2010 1 117 http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf

2. Antiretroviral pharmacology: special issues regarding pregnant women and neonates;Mirochnick;Clin Perinatol,2010

3. Drug transfer across the placenta. Considerations in treatment and research;Simone;Clin Perinatal,1994

4. Placental transfer of drugs administered to the mother;Pacifici;Clin Pharmacokinet,1995

5. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research Draft guidance for industry: pharmacokinetics in pregnancy-study design, data analysis, and impact on dosing and labeling 2004 www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM072133.pdf

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Precision Drug Therapy and build pharmacokinetic model in Pregnant Women: PBPK Modeling of Antiviral drugs;2024-07-22

2. Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women;Expert Opinion on Drug Metabolism & Toxicology;2024-05-14

3. Supporting Prospective Pregnancy Trials via Modeling and Simulation: Lessons From the Past and Recommendations for the Future;The Journal of Clinical Pharmacology;2023-06

4. Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy;Obstetrics and Gynecology Clinics of North America;2023-03

5. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach;Clinical Pharmacokinetics;2022-01-24